Your browser doesn't support javascript.
loading
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis.
Vijayaraghavan, Smruthi; Lipfert, Lorraine; Chevalier, Kristen; Bushey, Barbara S; Henley, Benjamin; Lenhart, Ryan; Sendecki, Jocelyn; Beqiri, Marilda; Millar, Hillary J; Packman, Kathryn; Lorenzi, Matthew V; Laquerre, Sylvie; Moores, Sheri L.
Afiliación
  • Vijayaraghavan S; Janssen Research & Development, Spring House, Pennsylvania. SVijayar@its.jnj.com.
  • Lipfert L; Janssen Research & Development, Spring House, Pennsylvania.
  • Chevalier K; Janssen Research & Development, Spring House, Pennsylvania.
  • Bushey BS; Janssen Research & Development, Spring House, Pennsylvania.
  • Henley B; Janssen Research & Development, Spring House, Pennsylvania.
  • Lenhart R; Janssen Research & Development, Spring House, Pennsylvania.
  • Sendecki J; Janssen Research & Development, Spring House, Pennsylvania.
  • Beqiri M; Janssen Research & Development, Spring House, Pennsylvania.
  • Millar HJ; Janssen Research & Development, Spring House, Pennsylvania.
  • Packman K; Janssen Research & Development, Spring House, Pennsylvania.
  • Lorenzi MV; Janssen Research & Development, Spring House, Pennsylvania.
  • Laquerre S; Janssen Research & Development, Spring House, Pennsylvania.
  • Moores SL; Janssen Research & Development, Spring House, Pennsylvania.
Mol Cancer Ther ; 19(10): 2044-2056, 2020 10.
Article en En | MEDLINE | ID: mdl-32747419
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Monocitos / Anticuerpos Biespecíficos / Antineoplásicos Inmunológicos / Macrófagos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Monocitos / Anticuerpos Biespecíficos / Antineoplásicos Inmunológicos / Macrófagos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article